JERILYN FARMER: Open Payments
NPI 1366749152 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 36 payments from 12 companies in 2025. Trend: 2023 $780 · 2024 $910 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $159 |
| Boston Scientific Corporation | 1 | $142 |
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| Merck Sharp & Dohme LLC | 5 | $111 |
| SCPHARMACEUTICALS INC. | 3 | $54 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
Products named: CAMZYOS, General - Structural Heart, LEQVIO, VERQUVO, FUROSCIX, LifeVest, Kerendia, EVKEEZA.
Industry payments across MS — which companies pay providers there.
